Dg Capital Management, LLC Provention Bio, Inc. Transaction History

Dg Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $422,908 - $692,929	-123,297 Reduced 19.8%	499,271 $2.25 Million
Q2 2022 Aug 12, 2022	BUY	$3.65 - $7.3 $365,000 - $730,000	100,000 Added 19.14%	622,568 $2.49 Million
Q1 2022 May 11, 2022	SELL	$3.4 - $7.88 $330,272 - $765,455	-97,139 Reduced 15.67%	522,568 $3.83 Million
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $421,961 - $557,834	75,485 Added 13.87%	619,707 $3.48 Million
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $3.08 Million - $4.53 Million	544,222 New	544,222 $3.48 Million

Q1 2021 May 13, 2021	SELL	$10.12 - $19.45 $4.49 Million - $8.62 Million	-443,331 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $309,357 - $496,966	26,239 Added 6.29%	443,331 $7.51 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $1.34 Million - $1.97 Million	129,920 Added 45.24%	417,092 $5.35 Million
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $2.24 Million - $4.88 Million	287,172 New	287,172 $4.05 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dg Capital Management, LLC with notifications on news.